Direct chronotropic effects of atrial and C-type natriuretic peptides in anaesthetized dogs

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1790-1796

  Beaulieu, Pierre ^a,b   Cardinal, René ^a,b   De Léan, André ^a   Lambert, Chantal ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Atrial natriuretic peptide (ANP); C type natriuretic peptide (CNP); Chronotropic effect; Sinoatrial node

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; LOSARTAN; MEPYRAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NATRIURETIC PEPTIDE TYPE C; PRAZOSIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; DOG; FEMALE; HEART CONDUCTION; HEART RATE; HEART RIGHT ATRIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SINUS NODE; SINUS RHYTHM; VAGOTOMY;

EID: 0029945295     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15605.x     Document Type: Article

References (50)

1. ACKERMANN, U., KHANNA, J. & IRIZAWA, T. (1988). Atrial natriuretic factor alters autonomic interactions in the control of heart rate in conscious rats. Can. J. Physiol. Pharmacol., 66, 930-936.
2. ATCHISON, D.J. & ACKERMANN, U. (1990). Influence of atrial natriuretic factor on autonomic control of heart rate. Am. J. Physiol., 258, R718-R723.
3. ATCHISON, D.J. & ACKERMANN, U. (1993). The interaction between atrial natriuretic peptide and cardiac parasympathetic function. J. Autonom. Nerv. Syst., 42, 81-88.
4. ATCHISON, D.J., PENNEFATHER, P.S. & ACKERMANN, U. (1993). ANP has no postsynaptic effect on autonomic regulation of cardiac pacemaker rate in the rat. Am. J. Physiol., 265, H1983-1987.
5. BAUM, T., SYBERTZ, E.J., WATKINS, R.W., NELSON, S., COLEMAN, W., PULA, K.K., PRIOLI, N., RIVELLI, M. & GROSSMAN, A. (1986). Hemodynamic actions of a synthetic atrial natriuretic factor. J. Cardiovasc. Pharmacol., 8, 898-905.
6. BIE, P., WANG, B.C., LEADLEY, Jr, R.J. & GOETZ, K.L. (1988). Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs. Am. J. Physiol., 254, R161-R169.
7. BROWN, L.A., NUNEZ, D.J.R. & WILKINS, M.R. (1993). Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J. Clin. Invest., 92, 2702-2712.
8. CANTIN, M., THIBAULT, G., HAILE-MESKEL, H., DING, J., MILNE, R.W., BALLAK, M., CHARBONNEAU, C., NEMER, M., DROUIN, J., GARCIA, R. & GENEST, J. (1989). Atrial natriuretic factor in the impulse-conduction system of rat cardiac ventricles. Cell Tissue Res., 256, 309-325.
9. CARGILL, R.I., COUTIE, W.J. & LIPWORTH, B.J. (1994). The effects of angiotensin II on circulating levels of natriuretic peptides. Br. J. Clin. Pharmacol., 38, 139-142.
10. CHARLES, C.J., ESPINER, E.A., RICHARDS, A.M. & DONALD, R.A. (1995). Central C-type natriuretic peptide augments the hormone response to hemorrhage in conscious sheep. Peptides, 16, 129-132.
11. CHRISMAN, T.D., SCHULZ, S., POTTER, L.R. & GARBERS, D.L. (1993). Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides. J. Biol. Chem., 268, 3698-3703.
12. CLAVELL, A.L., STINGO, A.J., WEI, C-M., HEUBLEIN, D.M. & BURNETT, JR, J.C. (1993). C-type natriuretic peptide: a selective cardiovascular peptide. Am. J. Physiol., 264, R290-R295.
13. EBERT, T.J. & COWLEY, JR, A.W. (1988). Atrial natriuretic factor attenuates carotid baroreflex-mediated cardioacceleration in humans. Am. J. Physiol., 254, R590-R594.
14. ESPINER, E.A. (1994). Physiology of natriuretic peptides. J. Intern. Med., 235, 527-541.
15. FRANCO-SAENZ, R., SOMANI, P. & MULROW, P.J. (1992). Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension. Am. J. Hypertens., 5, 266-275.
16. GISBERT, M-P. & FISCHMEISTER, R. (1988). Atrial natriuretic factor regulates the calcium current in frog isolated cardiac cells. Circ. Res., 62, 660-667.
17. GOETZ, K.L., WANG, B.C., GEER, P.G., SUNDET. W.D. & NEEDLEMAN, P. (1986). Effects of atriopeptin infusion versus effects of left atrial stretch in awake dogs. Am. J. Physiol., 250, R221 R226.
18. HAGEMAN, G.R., URTHALER, F., ISOBE, J.H. & JAMES, T.N. (1979). Chronotropic and dromotropic effects of histamine on the canine heart. Chest, 75, 597-604.
19. HENNING, R.J. (1992). Vagal stimulation during muscarinic and β-adrenergic blockade increases atrial contractility and heart rate. J. Autonom. Nerv. Syst., 40, 121-130.
20. HEUBLEIN, D., CLAVELL, A., STINGO, A., LERMAN, A., WOLD, L. & BURNETT, Jr, J.C. (1992). C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells. Peptides, 13, 1017-1019.
21. HIWATARI, M., SATOH, K., ANGUS, J.A. & JOHNSTON, C.I. (1986). No effect of atrial natriuretic factor on cardiac rate, force and transmitter release. Clin. Exp. Pharmacol. Physiol., 13, 163-168.
22. HUNT, P.J., RICHARDS, A.M., ESPINER, E.A., NICHOLLS, M.G. & YANDLE, T.G. (1994). Bioactivity and metabolism of C-type natriuretic peptide in normal man. J. Clin. Endocrinnl. Metab., 78, 1428-1435.
23. IMAIZUMI, T. & TAKESHITA, A. (1993). Influence of ANP on sympathetic nerve activity and chronotropic regulation of the heart. J. Cardiovasc. Electrophysiol., 4, 719-729.
24. JAMES, T.N. & NADEAU, R.A. (1962). Direct perfusion of the sinus node: an experimental model for pharmacologic and electrophysiologic studies of the heart. Henry Ford Hosp. Med. Bull., 10, 21-25.
25. KOMATSU, Y., NAKAO, K., ITOH, H., SUGA, S., OGAWA, Y. & IMURA, H. (1992). Vascular natriuretic peptide. Lancet, 340, 622.
26. LAMBERT, C. (1995). Mechanisms of angiotensin II chronotropic effect in anaesthetized dogs. Br. J. Pharmacol., 115, 795-800.
27. LAMBERT, C., RIBUOT, C., ROBICHAUD, A. & CUSSON, J.R. (1994). Negative chronotropic effect of the atrial natriuretic peptide in an anaesthetized dog model. Eur. J. Pharmacol., 252, 245-252.
28. LEVI, R., OWEN, D.A.A. & TRZECIAKOWSKI, J. (1982). Actions of histamine on the heart and vasculature. In Pharmacology of Histamine Receptors, ed. Ganellin, C.R. & Parsons, M.E. pp. 236-297. Bristol: Wright. PSG.
29. MURAD, F., RAPOPORT, R.M. & FISCUS, R. (1985). Role of cyclic-GMP in relaxations of vascular smooth muscle. J. Cardiovasc. Pharmacol., 7, S111-S118.
30. NUNEZ, D.J.R., DICKSON, M.C. & BROWN, M.J. (1992). Natriuretic peptide receptor mRNAs in the rat and human heart. J. Clin. Invest., 90, 1966-1971.
31. OSTERODE, W., NOWOTNY, P., VIERHAPPER, H. & WALDHAUSL, W. (1995). Kinetics of plasma cyclic GMP and atrial natriuretic peptide after intravenous, intramuscular and subcutaneous injection of 50 μg hANP in man. Horm. Metab. Res., 27, 100-103.
32. 2-receptor-mediated negative chronotropic effect of bradykinin in canine sinus node. Am. J. Physiol., 265, H876 H879.
33. RIGEL, D.F. (1988). Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT. Am. J. Physiol., 255, H311-H317.
34. ROWE, G.G. & HENDERSON, R.H. (1974). Systemic and coronary hemodynamic effects of sodium nitroprusside. Am. Heart J., 87, 83-87.
35. SAITO, A., KIMURA, S. & GOTO, K. (1986). Calcitonin gene-related peptide as potential neurotransmitter in guinea pig right atrium. Am. J. Physiol., 250, H693-H698.
36. SASAKI, A., KIDA, O., KANGAWA, K., MATSUO, J. & TANAKA, K. (1986). Involvement of sympathetic nerves in cardiosuppressive effects of α-human atrial natriuretic polypeptide (α-hANP) in anaesthetized rats. Eur. J. Pharmacol., 120, 345-349.
37. SCHIFFRIN, E.L., GARCIA, R. & KONRAD, E.M. (1993). Interactions of angiotensin II and atrial natriuretic peptide. In Cellular and Molecular Biology of the Renin-Angiotensin System. ed. Raizada, M.K., Phillips, M.I. & Sumners, C. pp. 433 468. Boca Raton: CRC Press.
38. STANASZEK, W.F., KELLERMAN, D., BROGDEN, R.N. & ROMANKIEWICZ, J.A. (1983). Prazosin update: a review of its pharmacological properties and therapeutic use in hypertension and heart failure. Drugs, 25, 339-384.
39. STINGO, A.J., CLAVELL, A.L., AARHUS, L.L. & BURNETT, JR, J.C. (1992). Cardiovascular and renal actions of C-type natríuretic peptide. Am. J. Physiol., 262, H308-H312.
40. SUDOH, T., MINAMINO, N., KANGAWA, K. & MATSUO, H. (1990). C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun., 168, 863-870.
41. SUGA, S-I., NAKAO, K., HOSODA, K., MUKOYAMA, M., OGAWA, Y., SHIRAKAMI, G., ARAI, H., SAITO, Y., KAMBAYASHI, Y., INOUYE, K. & IMURA, H. (1992). Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology, 130, 229-239.
42. 1-adrenoceptors: an overview. Pharmacol. Rev., 45, 147-175.
43. TRACHTE, G.J., KANWAL, S., ELMQUIST, B.J. & ZIEGLER, R.J. (1995). C-type natriuretic peptide neuromodulates via 'clearance' receptors. Am. J. Physiol., 268, C978-C984.
44. TSUTSUI, M., YANAGIHARA, N., MINAMI, K., KOBAYASHI. H., NAKASHIMA, Y., KUROIWA, A. & IZUMI, F. (1994). C-type natriuretic peptide stimulates catecholamine synthesis through the accumulation of cyclic GMP in cultured bovine adrenal medullary cells. J. Pharmacol. Exp. Ther., 268, 584-589.
45. VOLLMAR, A.M., GERBES, A.L., NEMER, M. & SCHULZ, R. (1993). Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs. Endocrinology, 132, 1872-1874.
46. WEI, C-M., AARHUS, L.L., MILLER, V.M. & BURNETT, JR, J.C. (1993). Action of C-type natriuretic peptide in isolated canine arteries and veins. Am. J. Physiol., 264, H71-H73.
47. WEI, C-M., HU, S., MILLER, V.M. & BURNETT, JR, J.C (1994). Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 205, 765-771.
48. WOODS, W.T., URTHALER, F. & JAMES, T.N. (1976). Spontaneous action potentials of cells in the canine sinus node. Circ. Res., 39, 76-82.
49. WRIGHT, R.S., MILLER, W.L., AARHUS, L.L. & BURNETT, JR, J.C. (1993). The differential actions of C-type natriuretic peptide and atrial natriuretic peptide on the canine coronary circulation. Am. J. Hypertens., 6, 16A.
50. ZEUZEM, S., OLBRICH, H.G., HAAK, T. & JUNGMANN, E. (1990). In vivo evidence that human atrial natriuretic factor-(99-126) (hANF) stimulates parasympathetic activity in man. Eur. J. Clin. Pharmacol., 39, 77-79.